Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital nutrient glutamine. Their findings, reported in this week in Nature Medicine, lay the groundwork for development of potential “paradigm-shifting” therapies targeting cancer cell metabolism that could be monitored non-invasively by positron-emission tomography (PET) imaging. {read more here}

This interactive, multidisciplinary conference will focus on new technology and systems, fast, dynamic imaging and low dose applications of Total Body PET in animal science and medicine.  {read more here}

In PET imaging, the amount of radiotracer dose correlates with the level of image quality. But what if artificial intelligence (AI) could enable PET to be performed using only 1% of current dose levels — speeding exam times, decreasing radiation exposure, lowering costs, and alleviating shortages in radiotracers? {read more here}

Combining PET scans with a novel radiotracer could help researchers track damage to myelin in the brain, providing insight into the treatment of multiple sclerosis (MS) as well as the development of other disorders, according to a preclinical study published online January 12 in Scientific Reports. {read more here}